1. 1646. Combined Resistance Analyses From Phase 2b Studies of Presatovir Treatment in RSV-Infected Adults. (26th November 2018) Authors: Porter, Danielle; Guo, Ying; Perry, Jason; Gossage, David; Watkins, Timothy; Chien, Jason; Jordan, Robert Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 537STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96. (December 2014) Authors: Creticos, Catherine; Brinson, Cynthia; Mcdonald, Cheryl; Segal-Maurer, Sorana; Brar, Indira; Wade, Barbara; Garner, Will; Porter, Danielle; De-Oertel, Shampa; Weinberg, Amy; Sparrow, Toni Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis. Issue 9 (September 2019) Authors: McMullan, Laura K; Flint, Mike; Chakrabarti, Ayan; Guerrero, Lisa; Lo, Michael K; Porter, Danielle; Nichol, Stuart T; Spiropoulou, Christina F; Albariño, César Journal: Lancet infectious diseases Issue: Volume 19:Issue 9(2019) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide. (30th January 2017) Authors: Margot, Nicolas A.; Wong, Pamela; Kulkarni, Rima; White, Kirsten; Porter, Danielle; Abram, Michael E.; Callebaut, Christian; Miller, Michael D. Journal: Journal of infectious diseases Issue: Volume 215:Number 6(2017:Mar. 15) Page Start: 920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial. (September 2021) Authors: Gaur, Aditya H; Cotton, Mark F; Rodriguez, Carina A; McGrath, Eric J; Helström, Elizabeth; Liberty, Afaaf; Natukunda, Eva; Kosalaraksa, Pope; Chokephaibulkit, Kulkanya; Maxwell, Heather; Wong, Pamela; Porter, Danielle; Majeed, Sophia; Yue, Mun Sang; Graham, Hiba; Martin, Hal; Brainard, Diana M; P... Journal: Lancet Issue: Volume 5:Number 9(2021) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. No Emergent Resistance in HIV-1 Infected Virologically-Suppressed Subjects Who Switched to R/F/TAF. (4th October 2017) Authors: Porter, Danielle; Kulkarni, Rima; Cao, Huyen; Sengupta, Devi; White, Kirsten Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study. (January 2016) Authors: van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; Arribas, José R.; Wohl, David A.; Rieger, Armin; Rachlis, Anita; Bloch, Mark; Segal-Maurer, Sorana; Garner, Will; Porter, Danielle; Bosse, Matthew; Piontkowsky, David; Chuck, Susan K.; De-Oertel, Shampa Journal: AIDS Issue: Volume 30:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. Issue 12 (December 2016) Authors: Gaur, Aditya H; Kizito, Hilda; Prasitsueubsai, Wasana; Rakhmanina, Natella; Rassool, Mohammed; Chakraborty, Rana; Batra, Jagmohan; Kosalaraksa, Pope; Luesomboon, Wicharn; Porter, Danielle; Shao, Yongwu; Myers, Michael; Ting, Lillian; SenGupta, Devi; Quirk, Erin; Rhee, Martin S Journal: Lancet Issue: Volume 3:Issue 12(2016) Page Start: e561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial. (September 2017) Authors: Natukunda, Eva; Gaur, Aditya H; Kosalaraksa, Pope; Batra, Jagmohan; Rakhmanina, Natella; Porter, Danielle; Shao, Yongwu; Zhang, Heather; Pikora, Cheryl; Rhee, Martin S Journal: Lancet Issue: Volume 1:Number 1(2017) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Issue 5 (May 2017) Authors: DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Martorell, Claudia T; de Wet, Joseph; Stellbrink, Hans-Jürgen; Molina, Jean-Michel; Post, Frank A; Valero, Ignacio Pérez; Porter, Danielle; Liu, YaPei; Cheng, Andrew; Quirk, Erin; SenGupta, Devi; Cao,... Journal: Lancet Issue: Volume 4:Issue 5(2017) Page Start: e205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗